Mutational analysis of neurotensin in familial restless legs syndrome

Movement Disorders

Volumn 19, Issue 1, 2004, Pages 90-94

  Desautels, Alex ^a,b   Turecki, Gustavo ^b   Xiong, Lan ^c   Rochefort, Daniel ^c   Montplaisir, Jacques ^a   Rouleau, Guy A ^b,c  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Chromosome 12; Genetics; Mutational analysis; Neurotensin (NTS); Restless legs syndrome (RLS)

Indexed keywords

NEUROTENSIN;

5' UNTRANSLATED REGION; ARTICLE; CANADA; CHROMOSOME 12Q; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; FEMALE; FRANCE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRON; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME;

5' UNTRANSLATED REGIONS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; DNA MUTATIONAL ANALYSIS; EXONS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRONS; NEUROTENSIN; PARESTHESIA; PEDIGREE; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RESTLESS LEGS SYNDROME; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS);

EID: 2342429206     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10617     Document Type: Article

References (23)

1. Ekbom KA. Restless legs syndrome. Acta Neurol Scand 1945; 158(Suppl.):4.
2. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994;17:739-743.
3. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-2141.
4. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 2000;54:1064-1068.
5. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep 1999;22:970-999.
6. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999;52:938-943.
7. Akpinar S. Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol 1982;39:739.
8. Staedt J, Steppe G, Kogler A, Munz D, Riemann H, Emrich D, Ruther E. Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus). J Neural Transm Gen Sect 1993;93:71-74.
9. Turjanski N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 1999;52:932-937.
10. Staedt J, Stoppe G, Kogler A, et al. Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS). J Neural Transm Gen Sect 1995;99: 187-193.
11. Ruottinen HM, Partinen M, Hublin C, Bergman J, Haaparanta M, Solin O, Rinne JO. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 2000;54:502-504.
12. Desautels A, Turecki G, Montplaisir J, Sequeira A, Verner A, Rouleau GA. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet 2001;69:1266-1270.
13. Ervin GN, Birkemo LS, Nemeroff CB, Prange AJ Jr. Neurotensin blocks certain amphetamine-induced behaviours. Nature 1981;291: 73-76.
14. Binder EB, Kinkead B, Owens MJ, Nemeroff CB. Neurotensin and dopamine interactions. Pharmacol Rev 2001;53:453-486.
15. Kalivas PW, Burgess SK, Nemeroff CB, Prange AJ Jr. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience 1983;8:495-505.
16. Quirion R, Chiueh CC, Everist HD, Pert A. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals. Brain Res 1985;327:385-389.
17. Szigethy E, Beaudet A. Correspondence between high affinity 125I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: a combined radioautographic and immunohistochemical light microscopic study. J Comp Neurol 1989;279:128-137.
18. Lambert PD, Gross R, Nemeroff CB, Kilts CD. Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system. Ann N Y Acad Sci 1995;757:377-389.
19. Sotty F, Souliere F, Brun P, et al. Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumhens: a combined in vivo electrochemical and electrophysiological study. Neuroscience 1998;85:1173-1182.
20. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995;10:634-642.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
22. Underhill PA, Jin L, Lin AA, et al. Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography. Genome Res 1997;7:996-1005.
23. Cossette P, Liu L, Brisebois K, et al. Mutation in the α1 subunit of the GABAA receptor in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 2002;31:184-189.